Ipamorelin/CJC-1295 (no DAC) is a high-purity, synergistic blend designed for advanced research into growth hormone (GH) pathways.  This formulation combines a selective GH secretagogue (Ipamorelin) with a short-acting GHRH analogue (CJC-1295) to produce a strong, clean GH pulse.  It is the ideal compound for studying hormonal signaling and short-term metabolic responses with precision.

Ipamorelin significantly increases plasma growth hormone (GH) levels in both animals and humans.^[1][3][5] In addition, ipamorelin stimulates body weight gain in animals.^[5] Like pralmorelin and GHRP-6, ipamorelin does not affect prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), or thyroid-stimulating hormone (TSH) levels.^[3] However, unlike pralmorelin (GHRP-2) and GHRP-6, but similarly to growth hormone-releasing hormone (GHRH), ipamorelin does not stimulate the secretion of adrenocorticotropic hormone (ACTH), or cortisol, and is highly selective for inducing the secretion only of GH.^[3]

Intended Use

This compound is strictly intended for in vitro and laboratory research only. It is not for human consumption, diagnostic, or therapeutic use. All buyers must be qualified professionals or institutions.